The good news first: Patient-reported outcomes (PRO) are basically the same in both the medical device and the pharmaceutical sectors. There are the general quality of life tools such as the EQ-5D or the Short-Form Survey questionnaires (e.g. SF-12, SF-36), and there are tools that target specific disease areas, such as the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Oswestry Disability Index (ODI).